Vitura HealthASX:VIT Gross Margin % is 22.74% as of Dec. 2025, which is 37% below its 10-year median of 36.26. The stock has 8 warning signs investors should review. Among 938 Drug Manufacturers companies, Vitura Health ranks worse than 87.21% on this metric.
Vitura Health Ltd gross margin has been in long-term decline. The average rate of decline per year is -20.9%.
The historical rank and industry rank for Vitura Health's Gross Margin % or its related term are showing as below:
ASX:VIT'
s Gross Margin % Range Over the Past 10 Years
Min: 25.01 Med: 36.26 Max: 94.35
Current: 25.01
During the past 7 years, the highestGross Margin % of Vitura Health was 94.35%. The lowest was 25.01%. And the median was 36.26%.
ASX:VIT's Gross Margin % is ranked worse than 87.21% of 938
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs ASX:VIT: 25.01
Vitura Health had a gross margin of 22.74% for the quarter that ended in Dec. 2025 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Vitura Health was -20.90% per year.
Vitura Health (ASX:VIT) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Vitura Health had a gross margin of 22.74% for the quarter that ended in Dec. 2025 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Vitura Health Gross Margin % Related Terms
Vitura Health Gross Margin % Historical Data
* Premium members only.
The historical data trend for Vitura Health's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Vitura Health's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vitura Health Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Vitura Health's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Vitura Health's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Vitura Health (ASX:VIT) has a Gross Margin % of 22.74% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Vitura Health and its competitors. This is 37% below median its historical median of 36.26. Over the past decade, Vitura Health's Gross Margin % has ranged from 25.01 to 94.35. According to the industry distribution chart, Vitura Health ranks #818 out of 938 companies in the Drug Manufacturers industry, placing it in the top 87.2%.
Is Vitura Health's Gross Margin % too high?
Vitura Health's current Gross Margin % of 22.74% is 37% below median its 10-year median of 36.26. Over the past 10 years, this metric has ranged from a low of 25.01 to a high of 94.35. The Drug Manufacturers industry median Gross Margin % is 48.54. Vitura Health's value of 22.74% is 53.2% below this industry median. Based on the distribution chart, Vitura Health ranks #818 out of 938 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Vitura Health's Gross Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Vitura Health ranks #818 out of 938 companies for Gross Margin %. This places Vitura Health in the lower half of its industry. The industry median Gross Margin % is 48.54. Vitura Health's value of 22.74% is 53.2% below this benchmark. Historically, Vitura Health's own Gross Margin % has ranged from 25.01 to 94.35 over the past decade. While the company's 10-year median is 36.26 vs. the industry median of 48.54, Vitura Health has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 938 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Vitura Health's current Gross Margin % of 22.74% is 53.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Vitura Health and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Vitura Health's current Gross Margin % is 22.74%, which is 37% below median its own 10-year median of 36.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vitura Health stock overvalued right now?
Based on GuruFocus' analysis, Vitura Health (ASX:VIT) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.10, compared to a current price of A$0.03 — trading 73% below its estimated fair value. The current Gross Margin % is 22.74%, which is 37% below median its 10-year median of 36.26 and 53.2% below the Drug Manufacturers industry median of 48.54. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Vitura Health (ASX:VIT), the current Gross Margin % is 22.74% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vitura Health Ltd is focused on creating medicinal cannabis products and digital health solutions that connect and strengthen the ecosystem between patients, prescribers, pharmacists, and suppliers. The company has two business segments namely, Sales and distribution (involving the sale and distribution of medical products including medicinal cannabis, psychedelic drugs, and smoking cessation products) and Clinics and services (involving the operation of medicinal cannabis clinics and the provision of related services). The company generates the majority of its revenue from the Sales and distribution segment. Geographically the company generates the majority of its revenue from Australia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:VIT has been successfully added to your 